CSIMarket
 
American Bio Medica Corporation  (ABMC)
Other Ticker:  
 
 
Price: $0.0003 $0.00 0.000%
Day's High: $0.0003 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: -40 %
Volume (M): 3 52 Wk High: $ 0.02
Volume (M$): $ 0 52 Wk Avg: $0.01
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 48
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

American Bio Medica Corporation
American Bio Medica Corporation is a company based in Kinderhook, New York that develops, manufactures, and sells immunoassay diagnostic test kits. The company specializes in rapid on-site drugs of abuse testing kits, including tests for drugs such as cocaine, marijuana, opioids, and amphetamines. Their products are mainly used in medical, law enforcement, and workplace settings. American Bio Medica Corporation is known for its easy to use and reliable testing kits that provide fast and accurate results, making it a trusted provider in the field of drugs of abuse testing.


   Company Address: 122 Smith Road Kinderhook 12106 NY
   Company Phone Number: 758-8158   Stock Exchange / Ticker: ABMC
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



American Bio Medica Corporation

Sievere Negative Oscillation Witnessed in the Q1 2023 Financial Performance of American Bio Medica Corporation

American Bio Medica Corporation Announces Balanced Book for Q1 2023
American Bio Medica Corporation, a leading producer of drug testing solutions, has announced its Q1 2023 financial results. The company reported balanced books of $0.00 per share in comparison to $0.00 a year earlier, and $-0.01 per share from the prior quarter. The announcement has generated interest from investors and analysts looking to evaluate the health of the company.
Notably, the revenue dropped sharply by -53.276% to $0.16 million from $0.35 million in the same quarter a year earlier, and sequentially Revenue decreased by -2.381% from $0.17 million. Despite this, the company saw net profits of $1.881 million in the first quarter of 2023, which is a significant improvement versus a net shortfall of $-0.379 million in the same quarter a year ago.






 

American Bio Medica's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com